Angiotensin receptor blockers and myocardial infarction.
Verma
Subodh
S
Strauss
Marty
M
D017311:Amlodipine / Q000009:adverse effects; D047228:Angiotensin II Type 1 Receptor Blockers / Q000009:adverse effects* / Q000627:therapeutic use; D000959:Antihypertensive Agents / Q000009:adverse effects*; D001562:Benzimidazoles / Q000009:adverse effects; D001713:Biphenyl Compounds; D006801:Humans; D006973:Hypertension / Q000188:drug therapy*; D009203:Myocardial Infarction / Q000139:chemically induced*; D013777:Tetrazoles / Q000009:adverse effects*; D014342:Truth Disclosure; D014633:Valine / Q000009:adverse effects* / Q000031:analogs & derivatives*; D000068756:Valsartan
D047228:Angiotensin II Type 1 Receptor Blockers; D000959:Antihypertensive Agents; D001562:Benzimidazoles; D001713:Biphenyl Compounds; D013777:Tetrazoles; D017311:Amlodipine; D000068756:Valsartan; D014633:Valine; C081643:candesartan